Matches in Wikidata for { <http://www.wikidata.org/entity/Q83128084> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q83128084 description "article scientifique publié en 2011" @default.
- Q83128084 description "artículu científicu espublizáu en xineru de 2011" @default.
- Q83128084 description "scientific article published on 04 January 2011" @default.
- Q83128084 description "wetenschappelijk artikel" @default.
- Q83128084 description "наукова стаття, опублікована в січні 2011" @default.
- Q83128084 name "Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)" @default.
- Q83128084 name "Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)" @default.
- Q83128084 type Item @default.
- Q83128084 label "Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)" @default.
- Q83128084 label "Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)" @default.
- Q83128084 prefLabel "Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)" @default.
- Q83128084 prefLabel "Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)" @default.
- Q83128084 P1433 Q83128084-E1D7BACF-AEEF-4BDF-B68B-3D1854AA160E @default.
- Q83128084 P1476 Q83128084-672B4B33-311D-4E37-BA96-F8CD80A0A69F @default.
- Q83128084 P2093 Q83128084-0234DF31-F166-4A46-9C2F-B08B4B09DE00 @default.
- Q83128084 P2093 Q83128084-12944088-94F3-4F10-A73A-B09F98068DAF @default.
- Q83128084 P2093 Q83128084-19894CAE-9BD3-443D-848A-C79FE3F8303E @default.
- Q83128084 P2093 Q83128084-3373330D-93A1-429A-9CAE-4BCDF6AF6592 @default.
- Q83128084 P2093 Q83128084-592D3709-9BFD-4327-9170-D97971A9F58B @default.
- Q83128084 P2093 Q83128084-62C384B2-E8B0-4C3C-9049-797610DBBCD1 @default.
- Q83128084 P2093 Q83128084-97AA9603-161E-40F0-8507-AA326CD42914 @default.
- Q83128084 P2093 Q83128084-B263D479-72F6-44EA-A1E6-792A648F2EA6 @default.
- Q83128084 P2093 Q83128084-B4FC3F79-340B-477D-B495-E749CF81A73E @default.
- Q83128084 P2093 Q83128084-D2438DCE-B391-44F4-B4E3-CA3E05245DB5 @default.
- Q83128084 P2093 Q83128084-D9E09BED-A6A7-41B5-918B-96E3D4BB7ED9 @default.
- Q83128084 P2093 Q83128084-ECFC0A17-B77C-4FE1-B448-2DBC2027EF00 @default.
- Q83128084 P2093 Q83128084-EE4DC05B-EC4A-40B0-BA47-80DF70369183 @default.
- Q83128084 P2093 Q83128084-F7DDF56B-EA1B-42FC-8BE3-8606972DB0E8 @default.
- Q83128084 P304 Q83128084-346EDB1B-392E-4704-88F9-5F25F71861A4 @default.
- Q83128084 P31 Q83128084-7CC3AD47-9BAA-412F-8C54-D0918E773189 @default.
- Q83128084 P356 Q83128084-C7ED6EEF-895F-4FE1-87A3-436058AB57FE @default.
- Q83128084 P433 Q83128084-7CD6663D-5106-49F2-B8F0-E3548CABE970 @default.
- Q83128084 P478 Q83128084-759F8188-4CA1-413B-BE69-A9F9D6AB9971 @default.
- Q83128084 P50 Q83128084-9537BD3E-3375-43E7-9A72-9CCCA3BF5FBD @default.
- Q83128084 P577 Q83128084-9059335F-F6CE-4D87-A6B1-F5217251A60B @default.
- Q83128084 P698 Q83128084-61EB1965-8874-42BB-90D1-F0E6388BFB67 @default.
- Q83128084 P921 Q83128084-3E3484D4-B1D2-4B5D-9090-AEC9660FD4E6 @default.
- Q83128084 P921 Q83128084-EAAA9FAF-E7C8-43ED-80B4-843E0481366D @default.
- Q83128084 P921 Q83128084-F87A410D-D87E-4D1A-A4B5-CB0ABBE2F450 @default.
- Q83128084 P356 JCO.2010.31.9715 @default.
- Q83128084 P698 21205757 @default.
- Q83128084 P1433 Q400292 @default.
- Q83128084 P1476 "Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)" @default.
- Q83128084 P2093 "Daniel Dietrich" @default.
- Q83128084 P2093 "Daniel Rauch" @default.
- Q83128084 P2093 "Helmut Kranzbuehler" @default.
- Q83128084 P2093 "Lucas Widmer" @default.
- Q83128084 P2093 "Michael Montemurro" @default.
- Q83128084 P2093 "Miklos Pless" @default.
- Q83128084 P2093 "Paul M Schneider" @default.
- Q83128084 P2093 "Peter Brauchli" @default.
- Q83128084 P2093 "Peter Moosmann" @default.
- Q83128084 P2093 "Roger von Moos" @default.
- Q83128084 P2093 "Roman Inauen" @default.
- Q83128084 P2093 "Thomas Ruhstaller" @default.
- Q83128084 P2093 "Viviane Hess" @default.
- Q83128084 P2093 "Walter Mingrone" @default.
- Q83128084 P304 "626-631" @default.
- Q83128084 P31 Q13442814 @default.
- Q83128084 P356 "10.1200/JCO.2010.31.9715" @default.
- Q83128084 P433 "6" @default.
- Q83128084 P478 "29" @default.
- Q83128084 P50 Q105531867 @default.
- Q83128084 P577 "2011-01-04T00:00:00Z" @default.
- Q83128084 P698 "21205757" @default.
- Q83128084 P921 Q18553999 @default.
- Q83128084 P921 Q420296 @default.
- Q83128084 P921 Q6934595 @default.